Gout: all 236 studies
Page 3 of 3. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of HuZhen Capsule for Treatment of Patients With Acute GoutStatus unknownNCT02674776Phase 3
- Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility StudyCompletedNCT02578394Phase 2/3
- Study of URC102 to Assess the Safety and Efficacy in Gout PatientsCompletedNCT02557126Phase 2
- DECT Study in Allopurinol-Treated Gout PatientsCompletedNCT02393560
- Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe GoutCompletedNCT02330796Phase 2
- A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia PatientsCompletedNCT02317861Phase 1/2
- Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout PatientsCompletedNCT02290210Phase 2
- Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With GoutCompletedNCT02252835Phase 2
- Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout PatientsCompletedNCT02063997Phase 2
- Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate LevelsCompletedNCT02060552Phase 4
- Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic RiskActive, not recruitingNCT02037321
- RDEA3170 Monotherapy in Subjects With GoutCompletedNCT01927198Phase 2
- The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic SyndromeStatus unknownNCT01818505
- Lesinurad and Allopurinol Combination Extension Study in GoutCompletedNCT01808131Phase 3
- Allopurinol in Acute GoutWithdrawnNCT01775098Not applicable
- A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With GoutCompletedNCT01736514Phase 3
- Evaluating the Effectiveness of a Chronic Disease Management Program for GoutCompletedNCT01568879Not applicable
- Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of LifeCompletedNCT01549210
- Postmarketing Study to Determine Performance of the SIGMA HP® PARTIAL KNEE SYSTEMCompletedNCT01529099Phase 4
- Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and GoutStatus unknownNCT01519687Phase 2
- Arthritis Research UK Gout Treatment Trial - Phase 2CompletedNCT01477346Not applicable
- CLinical Prediction Rule Score in VeteransWithdrawnNCT01418781
- Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout PatientsCompletedNCT01416402Phase 2
- A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal InsufficiencyCompletedNCT01407874Phase 2
- Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With GoutCompletedNCT01336686Phase 2
- Hereditary Tubulointerstitial NephritisCompletedNCT01312727Not applicable
- Initiation of Allopurinol at First Medical Contact for Acute Attacks of GoutCompletedNCT01310673Phase 4
- Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout ManagementCompletedNCT01151709
- Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/GoutCompletedNCT01129648Phase 2
- Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)CompletedNCT01109121Phase 2
- Allopurinol Combination StudyCompletedNCT01001338Phase 2
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With GoutCompletedNCT00985127Phase 2
- Phase III Trial of Febuxostat in Korea Gout PatientsCompletedNCT00821392Phase 3
- MRI and Ultrasound Findings in Patients With Gout and Normal Plain RadiographsCompletedNCT00584311Not applicable
- A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)CompletedNCT00142558Phase 4
- A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional TherapyCompletedNCT00080210Phase 2